TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

AstraZeneca Heart Drug Trial No Longer Subject of a Federal Probe
Play
INVESTING

Amarin Shares Crushed After Judge Rules Heart Drug Patents Invalid: Report

PRESS RELEASES

Grifols Partners With TRC Healthcare To Streamline Intravenous Compounding Education

PRESS RELEASES

Grifols' Anti-SARS-CoV-2 Hyperimmune Globulin Begins Clinical Trial In Patients With COVID-19

PRESS RELEASES

Grifols Closes The Acquisition Of Green Cross Fractionation Plant In Canada And 11 Plasma Centers In The U.S.

PRESS RELEASES

Grifols To Acquire Alkahest To Enhance Discovery Research And Development To Identify Innovative Therapies For Age-related Diseases Based Upon An Understanding Of The Human Plasma Proteome

PRESS RELEASES

ICU Medical Broadens Its Non-PVC/Non-DEHP IV Solutions Portfolio By Entering Long-Term U.S. Distribution Agreement With Grifols For Certain Core IV Solution Products

PRESS RELEASES

Grifols Delivers First Manufactured Batches Of Its Anti-SARS-CoV-2 Hyperimmune Globulin For Clinical Trials

PRESS RELEASES

Results Of Grifols' AMBAR Clinical Trial Published In Alzheimer's & Dementia: The Journal Of The Alzheimer's Association

PRESS RELEASES

Grifols To Acquire Green Cross Plasma Fractionation Facility In Montreal And A Plasma Collection Organization In The U.S. For US$460 Million

PRESS RELEASES

Rigel Announces Availability Of TAVLESSE® (Fostamatinib Disodium Hexahydrate) In Europe

PRESS RELEASES

Grifols Starts Production Of Its Hyperimmune Immunoglobulin As A Potential Passive Immune Therapy Against COVID-19

PRESS RELEASES

Racing Against Time, Medical Researchers, Life Science Companies And COVID-19 Survivors Launch National Campaign To Drive Blood Plasma Donation

PRESS RELEASES

Grifols Procleix Panther System With Automation Ready Technology (ART) Receives FDA Approval

PRESS RELEASES

Grifols Launches New 3-mL (900-IU) Vial For High-potency HyperRAB® (rabies Immune Globulin [human])

PRESS RELEASES

Grifols 2019 Annual Report On Form 20-F Filed With The SEC On April 6, 2020

AstraZeneca Heart Drug Trial No Longer Subject of a Federal Probe
INVESTING

Amarin Shares Crushed After Judge Rules Heart Drug Patents Invalid: Report

PRESS RELEASES

Grifols PharmacyKeeper Ranked No. 1 In KLAS Rating, Extends Category Leadership

Loxo Drug Notches Strikingly High Response Rates in Genetically Defined Tumors
MERGERS AND ACQUISITIONS

Hologic agrees to sell blood screening business to Grifols for $1.7B

Valeant Stock Jumps After John Paulson Named to Board
OPINION

5 big dividend stocks John Paulson loves

Today's Weak On High Volume Stock: Primero Mining (PPP)
MARKETS

3 Stocks Pulling The Health Services Industry Downward

3 Leisure Stocks Pushing Industry Growth
MARKETS

3 Stocks Pushing The Health Services Industry Higher

Today's Pre-Market Mover With Heavy Volume: Physicians Realty (DOC)
MARKETS

3 Health Services Stocks Driving The Industry Higher

New Lifetime High Reached By WGL Holdings (WGL)
MARKETS

Weak On High Volume: Grifols (GRFS)

Regeneron Pharmaceuticals Could Be Ready to Rebound
STOCKS

8 Biotech Stocks That Should Be in Your Portfolio Right Now

Barbarian At The Gate: Annaly Capital Management (NLY)
MARKETS

3 Stocks Raising The Health Services Industry Higher